You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal Junction

Showing 1 - 25 of 1,979
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2023

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with

Enrolling by invitation
  • Gastric / Gastroesophageal Junction Adenocarcinoma
  • envafolimab and lenvatinib combined with paclitaxel-albumin
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Sep 3, 2023

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

Not yet recruiting
  • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • XELOX combined with Fruquintinib and Sintilimab
  • (no location specified)
Oct 17, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • PD-1 inhibitor
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 9, 2023

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 17, 2023

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Esophageal Adenocarcinoma Trial in Clermont-Ferrand (Adipose tissue biopsies)

Not yet recruiting
  • Esophageal Adenocarcinoma
  • Adipose tissue biopsies
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
Jul 19, 2023

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

    Not yet recruiting
    • Gastric Cancer
    • S-1, Oxaliplatin, Cadonilimab
    • (no location specified)
    Jul 10, 2023

    Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

    Active, not recruiting
    • Gastric or Gastroesophageal Junction Adenocarcinoma
    • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Jul 4, 2023

    2D and 3D Primary Cell Cultures From Gastric and

    Not yet recruiting
    • Gastric and Gastroesophageal Junction Cancer
      • Berlin, Germany
        Department of Anesthesiology and Operative Intensive Care Medici
      Sep 13, 2022

      HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
      • SHR-A1811
      • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
      • (no location specified)
      Nov 6, 2023

      Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal Junction Adenocarcinoma
      • Beijing, Beijing, China
      • +10 more
      Nov 23, 2023

      Esophageal Cancer Trial (Hypofractionated radiotherapy)

      Not yet recruiting
      • Esophageal Cancer
      • Hypofractionated radiotherapy
      • (no location specified)
      Jan 18, 2023

      Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal Junction (GEJ) Cancer
      • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
      • (no location specified)
      Jun 7, 2023

      Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

      Not yet recruiting
      • Advanced Esophageal Adenocarcinoma
      • +14 more
      • (no location specified)
      Jan 3, 2023

      Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

      Recruiting
      • Adenocarcinoma
      • +8 more
      • Radiotherapy targeted to the primary lesion
      • +7 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 7, 2023

      Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

      Recruiting
      • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
      • +23 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 5, 2022

      Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal-junction Cancer
      • Tcrx T cell
      • (no location specified)
      Jul 21, 2022

      Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

      Recruiting
      • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
      • +10 more
      • Biopsy
      • +8 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 20, 2023

      Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

      Not yet recruiting
      • Gastric Cancer
      • +3 more
      • LB1908
      • (no location specified)
      Sep 9, 2022

      Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

      Recruiting
      • Gastric Adenocarcinoma
      • Adenocarcinoma of Gastroesophageal Junction
      • Docetaxel for injection (Albumin-bound)
      • Taxotere
      • Guangzhou, China
        Ethics Committee of Sun-Yat-Sen University Cancer Center
      Jan 27, 2023